US Stock MarketDetailed Quotes

CRBP Corbus Pharmaceuticals

Watchlist
  • 12.7500
  • -0.3900-2.97%
Close Dec 27 16:00 ET
  • 13.0000
  • +0.2500+1.96%
Post 18:52 ET
155.29MMarket Cap-2.71P/E (TTM)

Corbus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-94.29%-13.94M
-14.63%-8.94M
47.29%-7.97M
3.85%-36.1M
19.40%-6.01M
0.95%-7.18M
36.21%-7.8M
-42.39%-15.11M
22.08%-37.54M
23.16%-7.45M
Net income from continuing operations
-37.10%-13.78M
-13.81%-10M
61.12%-6.9M
-5.33%-44.6M
26.27%-8.02M
-14.48%-10.05M
33.70%-8.78M
-88.03%-17.74M
7.22%-42.35M
-6.03%-10.88M
Operating gains losses
----
----
572.86%6.41K
-102.72%-20.44K
----
----
----
-100.38%-1.36K
439.35%751.14K
51.82%-277.27K
Depreciation and amortization
-0.65%152K
-4.94%150.31K
-16.60%151.69K
-16.04%640.6K
-19.95%147.6K
-19.81%153K
-17.68%158.13K
-7.08%181.87K
-53.45%763K
-62.04%184.4K
Other non cash items
-51.14%107K
-59.74%91.33K
-6.69%187.67K
11.03%824.38K
-12.45%177.38K
20.06%219K
25.65%226.88K
13.69%201.12K
-21.89%742.48K
-57.67%202.61K
Change In working capital
-210.76%-2.03M
426.51%488.89K
-204.44%-1.49M
224.12%4.09M
-54.05%989.31K
17,075.71%1.83M
89.93%-149.73K
136.00%1.42M
78.98%-3.3M
192.70%2.15M
-Change in prepaid assets
22.71%-524K
407.74%424.01K
318.99%1.23M
-193.46%-1.47M
-169.45%-93.45K
-183.08%-678K
-132.84%-137.78K
-376.26%-561.22K
16.73%1.57M
153.15%134.55K
-Change in payables and accrued expense
-131.82%-1.37M
44.04%194.46K
-629.13%-2.76M
239.27%6.06M
-7.47%1.99M
723.08%4.32M
107.62%135.01K
90.60%-379.01K
75.65%-4.35M
150.08%2.15M
-Change in other current assets
7.31%235K
32.59%228.47K
157.59%434.54K
24.03%763.87K
21.69%203.87K
41.19%219K
15.33%172.31K
17.28%168.69K
228.21%615.9K
461.17%167.53K
-Change in other current liabilities
82.00%-365K
-12.15%-358.04K
-117.63%-386.96K
-10.70%-1.26M
-275.37%-1.11M
-601.73%-2.03M
-12.69%-319.26K
913.58%2.2M
-15.80%-1.14M
-23.67%-294.82K
Cash from discontinued investing activities
Operating cash flow
-94.29%-13.94M
-14.63%-8.94M
47.29%-7.97M
3.85%-36.1M
19.40%-6.01M
0.95%-7.18M
36.21%-7.8M
-42.39%-15.11M
22.08%-37.54M
23.16%-7.45M
Investing cash flow
Cash flow from continuing investing activities
-241.00%-15.37M
-286.66%-16.44M
-1,870.11%-98.24M
18.51%35.64M
-11.81%10.39M
282.49%10.9M
147.11%8.81M
-87.08%5.55M
140.96%30.07M
470.74%11.78M
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
82.33%-5.35K
--0
Net investment purchase and sale
-241.00%-15.37M
-286.66%-16.44M
-1,870.11%-98.24M
18.49%35.64M
-11.81%10.39M
282.49%10.9M
147.09%8.81M
-87.09%5.55M
140.99%30.08M
475.22%11.78M
Cash from discontinued investing activities
Investing cash flow
-241.00%-15.37M
-286.66%-16.44M
-1,870.11%-98.24M
18.51%35.64M
-11.81%10.39M
282.49%10.9M
147.11%8.81M
-87.08%5.55M
140.96%30.07M
470.74%11.78M
Financing cash flow
Cash flow from continuing financing activities
3,150.43%25.04M
194,039.19%34.96M
94,412.48%106.58M
-428.57%-2.82M
-912.78%-1.9M
-641.62%-821K
105.46%18.01K
65.45%-113.01K
-100.88%-533.62K
-69.49%234.32K
Net issuance payments of debt
-1,370.58%-10.9M
-1,391.56%-2.27M
-1,443.86%-2.32M
-438.58%-2.87M
-881.37%-1.83M
-569.35%-741K
53.97%-151.93K
54.13%-150.07K
-1,023.53%-533.62K
-69.49%234.32K
Net common stock issuance
45,026.25%35.94M
17,870.63%30.54M
311,833.25%115.59M
--244.3K
--117.3K
---80K
--169.94K
--37.06K
--0
--0
Net other financing activities
----
----
---6.69M
---190.9K
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
3,150.43%25.04M
194,039.19%34.96M
94,412.48%106.58M
-428.57%-2.82M
-912.78%-1.9M
-641.62%-821K
105.46%18.01K
65.45%-113.01K
-100.88%-533.62K
-69.49%234.32K
Net cash flow
Beginning cash position
170.05%24.36M
84.79%14.77M
-18.55%14.39M
-31.17%17.67M
-9.11%11.92M
-65.89%9.02M
-86.14%7.99M
-31.17%17.67M
-70.30%25.68M
-65.30%13.11M
Current changes in cash
-247.00%-4.26M
835.54%9.58M
103.92%379.44K
59.03%-3.28M
-45.71%2.47M
121.76%2.9M
103.28%1.02M
-130.23%-9.68M
86.83%-8M
137.64%4.56M
End cash Position
68.58%20.09M
170.05%24.36M
84.79%14.77M
-18.55%14.39M
-18.55%14.39M
-9.11%11.92M
-65.89%9.02M
-86.14%7.99M
-31.17%17.67M
-31.17%17.67M
Free cash flow
-94.29%-13.94M
-14.63%-8.94M
47.29%-7.97M
3.88%-36.1M
19.40%-6.01M
0.95%-7.18M
36.21%-7.8M
-42.21%-15.11M
22.14%-37.56M
23.59%-7.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -94.29%-13.94M-14.63%-8.94M47.29%-7.97M3.85%-36.1M19.40%-6.01M0.95%-7.18M36.21%-7.8M-42.39%-15.11M22.08%-37.54M23.16%-7.45M
Net income from continuing operations -37.10%-13.78M-13.81%-10M61.12%-6.9M-5.33%-44.6M26.27%-8.02M-14.48%-10.05M33.70%-8.78M-88.03%-17.74M7.22%-42.35M-6.03%-10.88M
Operating gains losses --------572.86%6.41K-102.72%-20.44K-------------100.38%-1.36K439.35%751.14K51.82%-277.27K
Depreciation and amortization -0.65%152K-4.94%150.31K-16.60%151.69K-16.04%640.6K-19.95%147.6K-19.81%153K-17.68%158.13K-7.08%181.87K-53.45%763K-62.04%184.4K
Other non cash items -51.14%107K-59.74%91.33K-6.69%187.67K11.03%824.38K-12.45%177.38K20.06%219K25.65%226.88K13.69%201.12K-21.89%742.48K-57.67%202.61K
Change In working capital -210.76%-2.03M426.51%488.89K-204.44%-1.49M224.12%4.09M-54.05%989.31K17,075.71%1.83M89.93%-149.73K136.00%1.42M78.98%-3.3M192.70%2.15M
-Change in prepaid assets 22.71%-524K407.74%424.01K318.99%1.23M-193.46%-1.47M-169.45%-93.45K-183.08%-678K-132.84%-137.78K-376.26%-561.22K16.73%1.57M153.15%134.55K
-Change in payables and accrued expense -131.82%-1.37M44.04%194.46K-629.13%-2.76M239.27%6.06M-7.47%1.99M723.08%4.32M107.62%135.01K90.60%-379.01K75.65%-4.35M150.08%2.15M
-Change in other current assets 7.31%235K32.59%228.47K157.59%434.54K24.03%763.87K21.69%203.87K41.19%219K15.33%172.31K17.28%168.69K228.21%615.9K461.17%167.53K
-Change in other current liabilities 82.00%-365K-12.15%-358.04K-117.63%-386.96K-10.70%-1.26M-275.37%-1.11M-601.73%-2.03M-12.69%-319.26K913.58%2.2M-15.80%-1.14M-23.67%-294.82K
Cash from discontinued investing activities
Operating cash flow -94.29%-13.94M-14.63%-8.94M47.29%-7.97M3.85%-36.1M19.40%-6.01M0.95%-7.18M36.21%-7.8M-42.39%-15.11M22.08%-37.54M23.16%-7.45M
Investing cash flow
Cash flow from continuing investing activities -241.00%-15.37M-286.66%-16.44M-1,870.11%-98.24M18.51%35.64M-11.81%10.39M282.49%10.9M147.11%8.81M-87.08%5.55M140.96%30.07M470.74%11.78M
Net PPE purchase and sale --------------0----------------82.33%-5.35K--0
Net investment purchase and sale -241.00%-15.37M-286.66%-16.44M-1,870.11%-98.24M18.49%35.64M-11.81%10.39M282.49%10.9M147.09%8.81M-87.09%5.55M140.99%30.08M475.22%11.78M
Cash from discontinued investing activities
Investing cash flow -241.00%-15.37M-286.66%-16.44M-1,870.11%-98.24M18.51%35.64M-11.81%10.39M282.49%10.9M147.11%8.81M-87.08%5.55M140.96%30.07M470.74%11.78M
Financing cash flow
Cash flow from continuing financing activities 3,150.43%25.04M194,039.19%34.96M94,412.48%106.58M-428.57%-2.82M-912.78%-1.9M-641.62%-821K105.46%18.01K65.45%-113.01K-100.88%-533.62K-69.49%234.32K
Net issuance payments of debt -1,370.58%-10.9M-1,391.56%-2.27M-1,443.86%-2.32M-438.58%-2.87M-881.37%-1.83M-569.35%-741K53.97%-151.93K54.13%-150.07K-1,023.53%-533.62K-69.49%234.32K
Net common stock issuance 45,026.25%35.94M17,870.63%30.54M311,833.25%115.59M--244.3K--117.3K---80K--169.94K--37.06K--0--0
Net other financing activities -----------6.69M---190.9K------------------------
Cash from discontinued financing activities
Financing cash flow 3,150.43%25.04M194,039.19%34.96M94,412.48%106.58M-428.57%-2.82M-912.78%-1.9M-641.62%-821K105.46%18.01K65.45%-113.01K-100.88%-533.62K-69.49%234.32K
Net cash flow
Beginning cash position 170.05%24.36M84.79%14.77M-18.55%14.39M-31.17%17.67M-9.11%11.92M-65.89%9.02M-86.14%7.99M-31.17%17.67M-70.30%25.68M-65.30%13.11M
Current changes in cash -247.00%-4.26M835.54%9.58M103.92%379.44K59.03%-3.28M-45.71%2.47M121.76%2.9M103.28%1.02M-130.23%-9.68M86.83%-8M137.64%4.56M
End cash Position 68.58%20.09M170.05%24.36M84.79%14.77M-18.55%14.39M-18.55%14.39M-9.11%11.92M-65.89%9.02M-86.14%7.99M-31.17%17.67M-31.17%17.67M
Free cash flow -94.29%-13.94M-14.63%-8.94M47.29%-7.97M3.88%-36.1M19.40%-6.01M0.95%-7.18M36.21%-7.8M-42.21%-15.11M22.14%-37.56M23.59%-7.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Ecopetrol
EC
0.00%
Petroleo Brasileiro SA Petrobras
PBR
-0.13%
Vale SA
VALE
-0.45%
Meta Platforms
META
-0.59%
Adobe
ADBE
-0.82%

Unlock the Full List